Berenbaum F, Griffin TM, Liu-Bryan R. Metabolic Regulation of Inflammation in Osteoarthritis. Arthritis & rheumatology (Hoboken, NJ). 2016.
van Steenbergen HW, van Nies JA, Ruyssen-Witrand A, Huizinga TW, Cantagrel A, Berenbaum F, et al. IL2RA is associated with persistence of rheumatoid arthritis. Arthritis research & therapy. 2015;17:244.
Trellu S, Dadoun S, Berenbaum F, Fautrel B, Gossec L. Intra-articular injections in thumb osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Joint, bone, spine : revue du rhumatisme. 2015;82(5):315-9.
Smolen JS, Emery P, Ferraccioli GF, Samborski W, Berenbaum F, Davies OR, et al. Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial. Annals of the rheumatic diseases. 2015;74(5):843-50.
 Reginster JY, Reiter-Niesert S, Bruyere O, Berenbaum F, Brandi ML, Branco J, et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthritis and cartilage. 2015;23(12):2086-93.
Nourissat G, Ornetti P, Berenbaum F, Sellam J, Richette P, Chevalier X. Does platelet-rich plasma deserve a role in the treatment of tendinopathy? Joint, bone, spine : revue du rhumatisme. 2015;82(4):230-4.
Nourissat G, Berenbaum F, Duprez D. Tendon injury: from biology to tendon repair. Nature reviews Rheumatology. 2015;11(4):223-33.
Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P, et al. Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort. PloS one. 2015;10(8):e0134974.
Nefla M, Sudre L, Denat G, Priam S, Andre-Leroux G, Berenbaum F, et al. The pro-inflammatory cytokine 14-3-3epsilon is a ligand of CD13 in cartilage. Journal of cell science. 2015;128(17):3250-62.
Louati K, Vidal C, Berenbaum F, Sellam J. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD open. 2015;1(1):e000077.
Louati K, Berenbaum F. Fatigue in chronic inflammation - a link to pain pathways. Arthritis research & therapy. 2015;17:254.
Laiguillon MC, Courties A, Houard X, Auclair M, Sautet A, Capeau J, et al. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthritis and cartilage. 2015;23(9):1513-22.
Gossec L, Saraux A, Hudry C, Mathoret-Philibert F, Poussiere M, de Chalus T, et al. Development and Validation of a Questionnaire Assessing the fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015;18(7):A708.
Gossec L, Chauvin P, Hudry C, Mathoret-Philibert F, Poussiere M, de Chalus T, et al. The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015;18(7):A715.
Goldring MB, Berenbaum F. Emerging targets in osteoarthritis therapy. Current opinion in pharmacology. 2015;22:51-63.
Gherghe AM, Dougados M, Combe B, Landewe R, Mihai C, Berenbaum F, et al. Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts. RMD open. 2015;1(1):e000128.
Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Annals of the rheumatic diseases. 2015;74(9):1725-33.
Dougados M, Etcheto A, Molto A, Alonso S, Bouvet S, Daures JP, et al. Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. Joint, bone, spine : revue du rhumatisme. 2015;82(5):345-51.
Depont F, Berenbaum F, Filippi J, Le Maitre M, Nataf H, Paul C, et al. Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review. PloS one. 2015;10(12):e0145076.
Deligne C, Casulli S, Pigenet A, Bougault C, Campillo-Gimenez L, Nourissat G, et al. Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients. Osteoarthritis and cartilage. 2015;23(11):1843-52.
Cutolo M, Berenbaum F, Hochberg M, Punzi L, Reginster JY. Commentary on recent therapeutic guidelines for osteoarthritis. Seminars in arthritis and rheumatism. 2015;44(6):611-7.
Courties A, Gualillo O, Berenbaum F, Sellam J. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis and cartilage. 2015;23(11):1955-65..
 Bruyere O, Cooper C, Arden N, Branco J, Brandi ML, Herrero-Beaumont G, et al. Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs & aging. 2015;32(3):179-87.
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet (London, England). 2015;385(9971):875-82.
Berenbaum F, van den Berg WB. Inflammation in osteoarthritis: changing views. Osteoarthritis and cartilage. 2015;23(11):1823-4.
Arden N, Richette P, Cooper C, Bruyere O, Abadie E, Branco J, et al. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty. Drugs & aging. 2015;32(7):525-35.